Success Metrics

Clinical Success Rate
85.7%

Based on 18 completed trials

Completion Rate
86%(18/21)
Active Trials
7(16%)
Results Posted
28%(5 trials)
Terminated
3(7%)

Phase Distribution

Ph not_applicable
20
45%
Ph phase_2
9
20%
Ph phase_3
5
11%
Ph phase_4
8
18%

Phase Distribution

0

Early Stage

9

Mid Stage

13

Late Stage

Phase Distribution42 total trials
Phase 2Efficacy & side effects
9(21.4%)
Phase 3Large-scale testing
5(11.9%)
Phase 4Post-market surveillance
8(19.0%)
N/ANon-phased studies
20(47.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

18 of 22 finished

Non-Completion Rate

18.2%

4 ended early

Currently Active

7

trials recruiting

Total Trials

44

all time

Status Distribution
Active(14)
Completed(18)
Terminated(4)
Other(8)

Detailed Status

Completed18
Not yet recruiting7
unknown7
Recruiting6
Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
44
Active
7
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 29 (21.4%)
Phase 35 (11.9%)
Phase 48 (19.0%)
N/A20 (47.6%)

Trials by Status

withdrawn12%
suspended12%
terminated37%
not_yet_recruiting716%
active_not_recruiting12%
completed1841%
recruiting614%
unknown716%

Recent Activity

Clinical Trials (44)

Showing 20 of 44 trialsScroll for more
NCT07393412

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

Recruiting
NCT07487532Not Applicable

Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation

Not Yet Recruiting
NCT06602609Not Applicable

Remote Cardiovascular Monitoring in Post-TAVI Patients

Recruiting
NCT07347626Phase 3

Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis

Not Yet Recruiting
NCT07335107Phase 3

Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion

Not Yet Recruiting
NCT07175948

Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital

Not Yet Recruiting
NCT07138144Phase 4

Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up

Recruiting
NCT07076693Phase 2

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC)

Active Not Recruiting
NCT06907056Phase 4

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico

Recruiting
NCT00614146Not Applicable

Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/or Encephalopathy and/or Renal Failure

Completed
NCT00287235Not Applicable

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

Completed
NCT06790927Not Applicable

Standardized Antihypertensive Treatment Protocol

Not Yet Recruiting
NCT06767241Not Applicable

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Completed
NCT04400981Not Applicable

Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

Completed
NCT04444349Not Applicable

Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)

Recruiting
NCT06703411Phase 4

Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

Completed
NCT06681038Phase 2

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)

Not Yet Recruiting
NCT06655259Phase 2

Combination of TURP and Standard Systemic Therapy for MPCa

Recruiting
NCT06325345Not Applicable

RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders

Not Yet Recruiting
NCT06155760Not Applicable

Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
44